Position in BMY
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$1,127,911
+$97,650 QoQ
Shares Held
19,575
+15.2% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#1,093
of 2,506 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RIVERSEDGE ADVISORS, LLC holds $8,081,117 across 10 Drug Manufacturers - General names. BMY ranks #4 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
6,231 | $1,582,487 | |
| 2 | LLY |
ELI LILLY & Co
|
1,159 | $1,390,139 | |
| 3 | ABBV |
AbbVie Inc.
|
4,666 | $1,174,152 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
19,575 | $1,127,911 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,880 | $884,080 | |
| 6 | NVS |
Novartis AG
|
3,883 | $608,543 | |
| 7 | AZN |
Astrazeneca PLC
|
2,280 | $432,333 | |
| 8 | BIIB |
Biogen Inc.
|
1,746 | $377,240 |
All Filings in BMY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,127,911 | 19,575 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $1,030,261 | 16,987 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $841,787 | 15,606 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $368,512 | 8,171 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $234,505 | 5,066 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $331,480 | 5,435 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $318,545 | 5,632 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $261,235 | 5,049 | Shares | Sole | 2024-10-16 | |
| 2024-03-31 | $292,191 | 5,388 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $265,785 | 5,180 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $330,305 | 5,691 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $352,556 | 5,513 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $402,968 | 5,814 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $446,665 | 6,208 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $429,383 | 6,040 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $465,080 | 6,040 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $441,028 | 6,039 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $376,531 | 6,039 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $357,327 | 6,039 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $389,694 | 5,832 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $368,174 | 5,832 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $394,262 | 6,356 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $356,916 | 5,920 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $347,860 | 5,916 | Shares | Sole | 2020-08-03 | |
| No filing history on record for this holder in this stock. | ||||||